Google has filed a patent for a contact lens system with built-in cameras, which essentially is a miniature version of its wearable Glass computer.
Advancements in nanotechnology are making an entry in ophthalmology and addressing the drug delivery challenge in the eye.
Five members of the Ophthalmic Women Leaders board of directors reflect on a noteworthy milestone in their ophthalmic careers.
ALG-1001 is the first of a new class of drugs, integrin peptide therapy, now going through clinical trials for patients with age-related macular degeneration, diabetic macular edema, and vitreomacular traction.
The next generation of biologic corneal bandage devices can reduce inflammation and promote healing for an extended range of ocular surface conditions from mild to severe.